Phosphorylation by the PknB Serine/Threonine Kinase Stimulates Dimer Formation by WalR
Biochemistry · 2026
DOI: 10.1021/acs.biochem.6c00334 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biochemistry, 2026. Verfasst von Marina Suppi und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, Temerty Faculty of Medicine, University of Toronto, 661 University Avenue, Toronto, OntarioM5G 1M1, Canada. Hauptthemen laut MEDLINE: Bacterial Proteins, Protein Serine-Threonine Kinases, Staphylococcus aureus. Die Arbeit nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: CIHR, Australian Research Council, National Health and Medical Research Council.
Abstract (Originalsprache)
WalKR is a two-component system that regulates cell wall homeostasis and other processes in low-GC Gram-positive bacteria. It is essential for viability in Staphylococcus aureus and regulates genes that encode the autolysins and other critical proteins. The sensor kinase WalK phosphorylates WalR at the aspartic acid residue 53 (D53) in the receiver domain, stimulating promoter DNA binding. Unlike most response regulators, WalR is reported to have a second kinase, the serine/threonine kinase PknB, which phosphorylates the receiver domain at the threonine residue 101. We previously reported that a walR mutation that changed T101 to a methionine conferred low-level resistance to vancomycin and greatly increased susceptibility to tunicamycin along with several other phenotypic traits. In this work, we demonstrate similarities between pknB null and the WalRT101M mutants. A combination of in vitro and in vivo data supports the idea that PknB interacts with WalR in living cells (consistent with similar experiments in Bacillus subtilis) and that this likely involves phosphorylation of WalR at T101. Using in silico modeling, we identified a possible intermolecular hydrogen bond between the T101 phosphate group and E108. This would have the effect of stabilizing the WalR dimerization interface. Consistent with this, we find that T101 is important for WalR dimer formation in vivo. The primary activation of WalR is clearly phosphorylation at D53 by WalK. However, our data suggest that PknB serves as a second potentiating input stabilizing the WalR dimer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Biochemistry, Temerty Faculty of Medicine, University of Toronto, 661 University Avenue, Toronto, OntarioM5G 1M1, Canada.
- Department of Microbiology and Immunology, Doherty Institute for Infection and Immunity, University of Melbourne, Melbourne, Victoria3000, Australia.
- Department of Microbiology & Biotechnology, University School of Sciences, Gujarat University, Ahmedabad380009Gujarat, India.
ORCID-Profile: Marina Suppi, Nichollas E Scott, Timothy P Stinear, Sacha J Pidot, Justin R Nodwell
Förderung
- CIHR
- Australian Research Council
- National Health and Medical Research Council
- University of Melbourne
- University of Toronto
- Canadian Institutes of Health Research
Zitieren
APA
Suppi, M., Monk, I. R., Sharkey, L. K. R., Scott, N. E., Goswami, D., Natarajan, A., Tan, S., Myler, K., Pimentel-Elardo, S. M., Stinear, T. P., Pidot, S. J., & Nodwell, J. R. (2026). Phosphorylation by the PknB Serine/Threonine Kinase Stimulates Dimer Formation by WalR. Biochemistry. https://doi.org/10.1021/acs.biochem.6c00334
Vancouver
Suppi M, Monk IR, Sharkey LKR, Scott NE, Goswami D, Natarajan A, et al. Phosphorylation by the PknB Serine/Threonine Kinase Stimulates Dimer Formation by WalR. Biochemistry. 2026. doi:10.1021/acs.biochem.6c00334
BibTeX
@article{Suppi2026,
author = {Suppi, Marina and Monk, Ian R and Sharkey, Liam K R and Scott, Nichollas E and Goswami, Dweipayan and Natarajan, Aakash and Tan, Stephanie and Myler, Katharine and Pimentel-Elardo, Sheila Marie and Stinear, Timothy P and Pidot, Sacha J and Nodwell, Justin R},
title = {Phosphorylation by the PknB Serine/Threonine Kinase Stimulates Dimer Formation by WalR},
journal = {Biochemistry},
year = {2026},
doi = {10.1021/acs.biochem.6c00334}
}
EUVIMED